VAT ID: DE316949626
Synonym: LY3437943
Specifications
| Purity | ≥99.0% |
| Identification | Conforms |
| Appearance | Lyophilized White to Off White Powder |
| Water Content | ≤8.0% |
| Trifluoroacetic Acid | ≤0.5% |
| Acetic Acid | ≤0.5% |
| Sodium Ion | ≤5.0% |
| Bacterial Endotoxin | <10EU/mg |
| Microbial Limits | Total Aerobic Microbial Count (TAMC) ≤1000cfu/g
Total Yeasts and Mold Count (TYMC) ≤100cfu/g |
| Assay of Peptide | ≥95.0% |
Conforms to Standard
Safety Information
Not a hazardous substance or mixture.
DOT: Not regulated.
Additional Information
This product ships on ice via FedEx Standard Overnight® or UPS Next Day Air® with free shipping included. Freeze upon arrival. Store at -20°C.
For research and development use only. Not for food, drug, household or other uses. Store at -20°C.
Retatrutide is a next-generation investigational peptide designed to support advanced metabolic regulation and weight management. As a triple receptor agonist, it targets key pathways involved in energy balance and glucose control, including GLP-1 (appetite regulation), GIP (insulin response), and the glucagon receptor (energy expenditure), making it one of the most promising compounds currently under research for comprehensive metabolic support.
Based on clinical research, retatrutide has demonstrated significant potential for weight management, appetite control, enhanced metabolic function, and improved glucose regulation. It is currently being studied for applications in obesity, metabolic health, and insulin sensitivity; however, it remains a research compound and is not FDA-approved for general use, and should be used for research purposes only.
Reviews
There are no reviews yet.